— Know what they know.
Not Investment Advice
Also trades as: IHL.AX (ASX) · $vol 0M

IXHL NASDAQ

Incannex Healthcare Limited
1W: -3.3% 1M: -1.8% 3M: -19.6% YTD: -72.6% 1Y: -75.2% 3Y: -97.8%
$3.21
-0.04 (-1.23%)
 
Weekly Expected Move ±8.6%
$3 $3 $3 $3 $4
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 34 · $38.4M mcap · 10M float · 1.97% daily turnover · Short 28% of daily vol

Income Trends

Revenue
$0 -100.0% ▼
Gross Profit
-$240K -50.0% ▼
Operating Income
-$23M +3.2% ▲
Net Income
-$19M +58.8% ▲
EPS (Diluted)
$-1.66 +95.9% ▲
EBITDA
-$23M +3.2% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2022FY2023FY2024FY2025FY2026
Revenue$0$0$18K$86K$0
YoY Growth-100.0%+0.0%+0.0%+378.7%-100.0%
Cost of Revenue$4K$0$0$0$240K
Gross Profit-$4K$0$18K$86K-$240K
Gross Margin——100.0%100.0%—
R&D Expenses$4M$6M$19M$11M$5M
SG&A Expenses$7M$8M$26M$13M$18M
Operating Expenses-$4K$14M$45M$24M$23M
Operating Income-$10M-$14M-$45M-$24M-$23M
Operating Margin——-250341.7%-27661.6%—
Interest Expense$0$0$0$303K$0
Income Before Tax-$10M-$49M-$28M-$47M-$24M
Tax Expense$0$0$45K-$2M-$5M
Net Income-$10M-$49M-$28M-$47M-$19M
Net Margin——-153825.0%-54517.4%—
EPS (Diluted)$-0.03$-3.17$-1.14$-40.80$-1.66
EBITDA-$10M-$14M-$28M-$48M-$23M
Shares Outstanding298M15M16M1M12M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms